Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prognostic Relevance of N-terminal Pro B-type Natriuretic Peptide(NTproBNP), Cerebral Oxygen Saturation (ScO2), and Preoperative Creatinine Clearance in Cardiac Surgery Patients - Amendment 2: the Role of NTproBNP and ScO2 in Predicting Mortality and Postoperative Organ Dysfunction.

NCT01409941 is registered in ClinicalTrials.gov with University of Luebeck as lead sponsor.

NCT NCT01409941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01409941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prognostic Relevance of N-terminal Pro B-type Natriuretic Peptide(NTproBNP), Cerebral Oxygen Saturation (ScO2), and Preoperative Creatinine Clearance in Cardiac Surgery Patients - Amendment 2: the Role of NTproBNP and ScO2 in Predicting Mortality and Postoperative Organ Dysfunction.
Lead sponsor
University of Luebeck
Phase
Observational
Overall status
Completed
Start date
January 31, 2009
Completion date
December 31, 2011
Enrollment
765 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

patients undergoing cardiac surgery